Stock VPA AVEO PHARMACEUTICALS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Analyst Reco. AVEO Pharmaceuticals, Inc. Börse Stuttgart

Equities

VPA

US0535881090

Delayed Börse Stuttgart
Other stock markets
 08:03:53 05/10/2021 pm IST 		5-day change 1st Jan Change
5.28 EUR -0.19% Intraday chart for AVEO Pharmaceuticals, Inc. -10.02% +20.93%
25/03 AVEO Pharmaceuticals, Inc. Announces Executive Changes CI
06/02 Aveo Oncology Announces Publication of Long-Term Survival in Patients with Relapsed/Refractory Advanced Renal Cell Carcinoma Treated with Tivozanib: Analysis of the Phase Iii Tivo-3 Trial in the Oncologist CI

Analyst Reco.

Search
See the results
Unlock all the news: Be the first to know and act before the market!
100% Free Registration
Stifel Downgrades AVEO Pharmaceuticals to Hold From Buy, Price Target is $15
MT
JonesTrading Downgrades AVEO Pharmaceuticals to Hold From Buy With $15 Price Target
MT
SVB Securities Downgrades AVEO Pharmaceuticals to Market Perform From Outperform, Retains Price Target at $15
MT
Baird Downgrades AVEO Pharmaceuticals to Neutral From Outperform, Adjusts Price Target to $15 From $17
MT
HC Wainwright Downgrades AVEO Pharmaceuticals to Neutral From Buy, Lowers Price Target to $15 From $19
MT
JonesTrading Initiates AVEO Pharmaceuticals With Buy Rating, $12 Price Target
MT
AVEO PHARMACEUTICALS : HC Wainwright Adjusts Price Target on AVEO Pharmaceuticals to $19 From $27, Keeps Buy Rating
MT
AVEO PHARMACEUTICALS : SVB Leerink Adjusts AVEO Oncology's Price Target to $18 from $10, Keeps Outperform Rating
MT
AVEO PHARMACEUTICALS : SVB Leerink Adjusts AVEO Oncology's Price Target to $10 From $7, Keeps at Outperform
MT
AVEO PHARMACEUTICALS : Stifel Reinstates AVEO Oncology at Buy with $9 Price Target
MT
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. AVEO Stock
  4. VPA Stock
  5. News AVEO Pharmaceuticals, Inc.
  6. Analyst Reco.